First Wave Biopharma Stock Number Of Employees
FWBIDelisted Stock | USD 0.61 0.03 4.69% |
First Wave BioPharma fundamentals help investors to digest information that contributes to First Wave's financial success or failures. It also enables traders to predict the movement of First Stock. The fundamental analysis module provides a way to measure First Wave's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to First Wave stock.
First |
First Wave BioPharma Company Number Of Employees Analysis
First Wave's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current First Wave Number Of Employees | 9 |
Most of First Wave's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, First Wave BioPharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, First Wave BioPharma is currently employing 9.0 people. This is 99.92% lower than that of the Biotechnology sector and 98.32% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.95% higher than that of the company.
First Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses First Wave's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of First Wave could also be used in its relative valuation, which is a method of valuing First Wave by comparing valuation metrics of similar companies.First Wave is currently under evaluation in number of employees category among its peers.
First Fundamentals
Return On Equity | -0.15 | |||
Return On Asset | -0.27 | |||
Current Valuation | 72.56 M | |||
Shares Outstanding | 2.03 M | |||
Shares Owned By Insiders | 5.66 % | |||
Shares Owned By Institutions | 1.46 % | |||
Number Of Shares Shorted | 46.6 K | |||
Price To Book | 1.87 X | |||
EBITDA | (15.74 M) | |||
Net Income | (15.79 M) | |||
Cash And Equivalents | 1.16 M | |||
Cash Per Share | 0.83 X | |||
Total Debt | 826.84 K | |||
Debt To Equity | 0.08 % | |||
Current Ratio | 0.10 X | |||
Book Value Per Share | 7.99 X | |||
Cash Flow From Operations | (12.38 M) | |||
Short Ratio | 1.02 X | |||
Earnings Per Share | (47.88) X | |||
Target Price | 36.0 | |||
Beta | 1.28 | |||
Market Capitalization | 5.99 M | |||
Total Asset | 6.88 M | |||
Retained Earnings | (184.33 M) | |||
Working Capital | 1.82 M | |||
Net Asset | 6.88 M |
About First Wave Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze First Wave BioPharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of First Wave using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of First Wave BioPharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in First Stock
If you are still planning to invest in First Wave BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the First Wave's history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |